21 CFR 211.194
Complete test data included in records
- Inspections citing it: 1,184
- Of those classified, ended OAI: 27%
- Last cited: FY2026
Inspections Citing It by Fiscal Year
Sites in and outside the US, FY2017 to Oct 20, 2026.
Paragraphs Cited
As FDA posts them, all years.
- 211.194(a)
- 330 · Complete test data included in records
- 211.194(a)(8)
- 221 · Second person sign off
- 211.194(a)(4)
- 159 · Complete Test Data
- 211.194(a)(2)
- 138 · Suitability of testing methods verified
- 211.194(d)
- 71 · Laboratory equipment calibration records
- 211.194(c)
- 69 · Testing and standardization of standards et. al.
- 211.194(a)(5)
- 47 · Calculations performed are in the records
- 211.194(a)(1)
- 41 · Sample identification and other information
Regulation Text
eCFR did not answer; open it on eCFRRecently Cited Sites
Newest inspections citing this section; each opens the site- Noven Pharmaceuticals, Inc.United States · Aug 24, 2026
- Alder Biochem Private LimitedIndia · Aug 14, 2026
- PDA Laboratories, Inc.United States · Aug 13, 2026
- Steril-Gene Life Sciences Private LtdIndia · Aug 12, 2026
- Bushu Pharmaceuticals Ltd.Japan · Aug 3, 2026
- S.s.s. Company (international)United States · Jun 26, 2026
- The Procter & Gamble Manufacturing CompanyUnited States · Jun 9, 2026
- Access Business Group LLCUnited States · Jun 5, 2026
- Nexus Pharmaceuticals, LLCUnited States · Jun 4, 2026
- Eurofins SF Analytical Laboratories, Inc.United States · Jun 3, 2026
- Pace Analytical Life Sciences, LLCUnited States · May 29, 2026
- Canyon Rush, LLCUnited States · May 15, 2026
Counts are inspections with posted citations that cite any paragraph of the section, once per inspection, from FDA's Data Dashboard. OAI share is over inspections FDA finally classified. Text from eCFR, the official online CFR. FDA Data Dashboard and eCFR